LeoPlouffeIIMD

Obstetrics & Gynecology • Amelia Island, FL

Reproductive Endocrinology & Infertility

VP Head of Global Patient Safety Gilead Sciences Inc.

Join to view full profile

Dr. Plouffe is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Plouffe's full profile

Already have an account?

Office
23 Beach Walker Rd
Amelia Island, FL 32034
Phone+1 973-303-7349
Is this information wrong?

Education & Training

Medical College of GeorgiaFellowship, Reproductive Endocrinology and Infertility, 1985 - 1987
McGill University Faculty Medicine HospitalObstetrics and Gynecology, 1981 - 1985
McGill University Faculty of MedicineClass of 1980

Certifications & Licensure

FL State Medical License 2021 - 2026
IN State Medical License 1998 - 2025
GA State Medical License 1985 - 2021
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Reproductive Endocrinology/Infertility

Awards, Honors, & Recognition

Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Publications & Presentations

PubMed

4 citations
Incorporating Pharmacometrics into Pharmacoeconomic Models: Applications from Drug Development.
Meenakshi Srinivasan, Annesha White, Ayyappa Chaturvedula, Valvanera Vozmediano, Stephan Schmidt, Leo Plouffe, La’Marcus M.T. Wingate> ;Pharmacoeconomics. 2020 Oct 1
2 citations
Does switching contraceptive from oral to a patch or vaginal ring change the likelihood of timely prescription refill
Amy Law, Yi-Chien Lee, Magdaliz Gorritz, Leo Plouffe> ;Contraception. 2014 Aug 1
73 citations
The effects of combined raloxifene and oral estrogen on vasomotor symptoms and endometrial safety.
Dale W Stovall, Wulf H. Utian, Margery Gass, Yongming Qu, David Muram, Mayme Wong, Leo Plouffe> ;Menopause. 2007 May 1
51 citations
Comparative effects of raloxifene and alendronate on fracture outcomes in postmenopausal women with low bone mass.
Robert R. Recker, David L. Kendler, Christopher Recknor, Theodore W. Rooney, E. Michael Lewiecki, Wulf H. Utian, Jane A. Cauley, Joanne Lorraine, Yongming Qu, Panduran...> ;Bone. 2007 Apr 1
7 citations
Duloxetine in the treatment of women with stress urinary incontinence: results from DESIRE (Duloxetine Efficacy and Safety for Incontinence in Racial and Ethnic popula...
David L. Weinstein, Jay S. Cohen, Chaofeng Liu, Eric S. Meadows, Leo Plouffe, David Muram> ;Current Medical Research and Opinion. 2006 Sep 26
6 citations
Endometrial effects of bazedoxifene acetate, a novel selective estrogen receptor modulator, in postmenopausal women.
Draper Michael William, Leo Plouffe> ;Obstetrics and Gynecology. 2005 Nov 1
13 citations
The dopamine receptor D2 genotype is associated with hyperprolactinemia
Keith A. Hansen, Yueyi Zhang, R. Colver, Sandra P.T. Tho, Leo Plouffe, Paul G. McDonough> ;Fertility and Sterility. 2005 Sep 1
108 citations
Safety and adverse effects associated with raloxifene: multiple outcomes of raloxifene evaluation.
Deborah Grady, Bruce Ettinger, Elena Moscarelli, Leo Plouffe, Somnath Sarkar, Angelina V. Ciaccia, Steven R. Cummings> ;Obstetrics and Gynecology. 2004 Oct 1
4 citations
Rationale for a non-inferiority clinical trial design focused on subpopulations.
Pandurang M. Kulkarni, Eric S. Meadows, Sanjeev Ahuja, David Muram, Leo Plouffe> ;Current Medical Research and Opinion. 2004 Sep 9
37 citations
Comparison of fracture, cardiovascular event, and breast cancer rates at 3 years in postmenopausal women with osteoporosis.
Stuart L. Silverman, Pierre D. Delmas, Pandurang M. Kulkarni, John L. Stock, Mayme Wong, Leo Plouffe> ;Journal of the American Geriatrics Society. 2004 Sep 1
18 citations
Transition from estrogen-progestin to raloxifene in postmenopausal women: effect on vasomotor symptoms.
Stephen Gordon, Brian W. Walsh, Angelina V. Ciaccia, Suresh Siddhanti, Amy Rosen, Leo Plouffe> ;Obstetrics and Gynecology. 2004 Feb 1
21 citations
Antiresorptive treatment of postmenopausal osteoporosis: review of randomized clinical studies and rationale for the Evista alendronate comparison (EVA) trial.
Edward G. Lufkin, Somnath Sarkar, Pandurang M. Kulkarni, Angelina V. Ciaccia, Suresh Siddhanti, John L. Stock, Leo Plouffe> ;Current Medical Research and Opinion. 2004 Jan 14
19 citations
Effect of raloxifene on sexual function in postmenopausal women.
B. Kessel, L Nachtigall, Leo Plouffe, Suresh Siddhanti, Amy Rosen, Anna K. Parsons> ;Climacteric. 2003 Sep 1
79 citations
Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years.
Elaine E. Jolly, Nina Hannover Bjarnason, Patrick Neven, Leo Plouffe, C. Conrad Johnston, Steven Watts, Claude D. Arnaud, Timothy M. Mason, Gerald Crans, Robin Akers, ...> ;Menopause. 2003 Jul 1
39 citations
Effect of raloxifene on the response to conjugated estrogen vaginal cream or nonhormonal moisturizers in postmenopausal vaginal atrophy
Anna K. Parsons, Diane F. Merritt, Amy Rosen, Hunter Heath, Suresh Siddhanti, Leo Plouffe> ;Obstetrics and Gynecology. 2003 Feb 1
17 citations
Effects of oral raloxifene on serum estradiol levels and other markers of estrogenicity.
Richard H. Reindollar, William Koltun, Anna K. Parsons, Amy Rosen, Suresh Siddhanti, Leo Plouffe> ;Fertility and Sterility. 2002 Sep 1
51 citations
Raloxifene effect on frequency of surgery for pelvic floor relaxation.
Steven R. Goldstein, Patrick Neven, Lifen Zhou, Yolanda L Taylor, Angelina V. Ciaccia, Leo Plouffe> ;Obstetrics and Gynecology. 2001 Jul 1
139 citations
A pharmacological review of selective oestrogen receptor modulators
Steven R. Goldstein, Suresh Siddhanti, Angelina V. Ciaccia, Leo Plouffe> ;Human Reproduction Update. 2000 May 1
12 citations
Disorders of excessive hair growth in the adolescent.
Leo Plouffe> ;Obstetrics and Gynecology Clinics of North America. 2000 Mar 1
50 citations
Selective estrogen receptor modulators (SERMs) in clinical practice.
Leo Plouffe> ;Journal of the Society for Gynecologic Investigation. 2000 Jan 1
85 citations
Uterine Effects of 3-year Raloxifene Therapy in Postmenopausal Women Younger Than Age 60
Fredric J. Cohen, Steven Watts, Aarti Shah, Robin Akers, Leo Plouffe> ;Obstetrics and Gynecology. 2000 Jan 1
57 citations
Healthcare use among U.S. women aged 45 and older: total costs and costs for selected postmenopausal health risks.
Thomas J. Hoerger, Kristen E. Downs, Mark Lakshmanan, Richard C. Lindrooth, Leo Plouffe, Brett Wendling, Suzanne L. West, Robert L. Ohsfeldt> ;Journal of Women's Health & Gender-Based Medicine. 1999 Oct 1
146 citations
Adverse events reported by postmenopausal women in controlled trials with raloxifene.
Graham C. Davies, William J. Huster, Yili Lu, Leo Plouffe, Mark Lakshmanan> ;Obstetrics and Gynecology. 1999 Apr 1
43 citations
Endometrial response to raloxifene compared with placebo, cyclical hormone replacement therapy, and unopposed estrogen in postmenopausal women.
Graham C. Davies, William J. Huster, Wei Shen, Bruce H. Mitlak, Leo Plouffe, Aarti Shah, Fredric J. Cohen> ;Menopause. 1999 Jan 1
10 citations
The role of p53 tumor suppressor gene and bcl-2 protooncogene in rat corpus luteum death ☆ ☆☆ ★
Edward A. Trott, Leo Plouffe, Keith A. Hansen, Paul G. McDonough, Puthenpura George, Iqbal Khan> ;American Journal of Obstetrics and Gynecology. 1997 Aug 1
Join now to see all